Michelle Geddes

High Busulfan Exposure Is Associated with Worse Outcomes in a Daily i.v. Busulfan and Fludarabine Allogeneic Transplant Regimen

Michelle Geddes, Shahbal B. Kangarloo, Naveed Farrukh et al. · Biology of Blood and Marrow Transplantation · 2008 · 146 citations · Full text

Mixed-phenotype Acute Leukemia, Transplantation Medicine, Immunology +24

The use of complementary therapies by breast cancer patients attending conventional treatment

Emanuele Crocetti, Nadia Crotti, Alessandra Feltrin et al. · European Journal of Cancer · 1998 · 129 citations

Nursing, Breast Oncology, Oncology +10

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

Rena Buckstein, Richard A. Wells, Nancy Zhu et al. · British Journal of Haematology · 2016 · 96 citations · Full text

Allogeneic Transplantation for Adult Acute Leukemia in First and Second Remission with a Novel Regimen Incorporating Daily Intravenous Busulfan, Fludarabine, 400 CGY Total-Body Irradiation, and Thymoglobulin

James A. Russell, Mary Lynn Savoie, A. Balogh et al. · Biology of Blood and Marrow Transplantation · 2007 · 79 citations · Full text

Transplantation Medicine, Immunology, Immunotherapy +18

Overall survival in lower <scp>IPSS</scp> risk <scp>MDS</scp> by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: an <scp>MDS</scp>‐<scp>CAN</scp> analysis

Heather A. Leitch, Ambica Parmar, Richard A. Wells et al. · British Journal of Haematology · 2017 · 61 citations · Full text